Can antihistamines really help with PMDD and menopausal symptoms?

Can antihistamines really help with PMDD and menopausal symptoms?

Women suffering from premenstrual dysphoric disorder (PMDD) and menopause are turning to a combination of over-the-counter antihistamines, specifically Allegra and Pepcid, in an attempt to alleviate debilitating symptoms such as intense emotional changes and exhaustion. This trend, which has been circulating on social media, suggests that the combination of these two medications can provide significant relief. Dr Alison Huang, a professor and director of the Women's Health Clinical Research Center at the University of California, San Francisco, notes that when conventional treatments fail to provide relief, it is understandable that women would seek alternative solutions. The use of antihistamines to treat PMDD and menopausal symptoms is based on the idea that histamine, a chemical released by the immune system, may play a role in exacerbating these symptoms. Histamine has several functions in the body, including triggering allergy symptoms, and there are four types of histamine receptors, with H1 and H2 receptors being the most relevant in this context. H1 antihistamines, such as Allegra, block the H1 receptors, reducing the severity of allergy symptoms, while H2 blockers, like Pepcid, primarily affect stomach cells and can help with issues like increased stomach acid secretion.

The potential link between histamine and perimenopausal symptoms is based on the fact that estradiol, a form of estrogen, can stimulate mast cells, which release histamine. This connection is supported by the observation that allergy symptoms can flare up during menstrual cycles and perimenopause. However, despite this known link, experts agree that there is not enough evidence to prove that histamine is a significant cause of perimenopausal symptoms like brain fog, anxiety, and hot flashes. Dr Amy Voedisch, a clinical associate professor of obstetrics and gynecology at Stanford University, notes that while there is a plausible reason to think that histamine and perimenopause might be connected, the current consensus is that perimenopausal symptoms are not histamine-driven. Anecdotal reports suggest that some women have experienced improvements in their hot flashes after taking Allegra or Pepcid for other conditions, but these reports are not supported by robust scientific evidence. The use of H1 and H2 antihistamines as a first-line treatment for mast cell activation syndrome, a condition related to excessive histamine release, may have inspired some women to try this combination for hormonal symptoms. Jessica Peters, a clinical psychologist and associate professor at Brown University, suggests that this use may have contributed to the online trend of using antihistamines to address hormonal symptoms.

Further research is needed to determine whether histamines can worsen perimenopausal symptoms, as the current evidence is limited and inconclusive. A 1976 paper suggests that histamine levels may fluctuate across the menstrual cycle and may be linked to estrogen, while limited research on rodents suggests that histamine can affect the parts of the brain involved in anxiety and stress. However, more recent research on the links between menstrual cycle changes, symptom severity, and the immune system has yielded mixed results. The International Association of Premenstrual Disorders (IAPMD) has noted that there is insufficient evidence to conclude that histamine tolerance, mast cell activation, or related immune mechanisms are a primary cause of pre-menstrual disorders. Despite this, some experts, such as Jennifer Gordon, an associate professor and director of the Reproductive Mental Health Research Unit at the University of Regina, believe that histamine and immune system processes may play a role in PMDD symptoms for some individuals. As a result, further studies are necessary to fully understand the potential relationship between histamine and PMDD and menopausal symptoms, and to determine whether antihistamines can provide a effective treatment option for these conditions.

Sources cited: 📰 Guardian Health ↗

⚡ Effects Interpreter

🌍World Economy

  • Global supply chains might feel a small tremor as businesses adjust.
  • Investors abroad often reprice their bets when this kind of news lands.

🏙️Local Economy

  • Local suppliers who import goods could pass on any change in costs.
  • Prices at your local shops could feel a gentle, indirect squeeze from this.

🏦Rates & Banks

  • Interest rates and mortgage bills are unlikely to jump straight away from this alone.
  • Central banks watch moments like this closely, so keep an eye on savings rates.

❤️Health

  • Small, sensible precautions can go a long way here.
  • Peace of mind often starts with reliable information.

💷Wealth

  • Healthcare or insurance costs might edge up if treatments become common.
  • Days lost to illness can gradually dent household income.

🏠Housing

  • House prices and rents are unlikely to shift the moment this news breaks.
  • The property market tends to move slowly, so expect any change to take time.
Share: 𝕏 Twitter Facebook LinkedIn WhatsApp

Editorial note: This analysis was produced by the News Effects Interpreter, an AI editorial tool that cross-references 1 independent news sources and contextualises events in terms of their real-world impact on ordinary people. Original reporting is linked above. News Effects does not alter the facts of source reports.